Ibrutinib-MPEA |
カタログ番号GC38106 |
イブルチニブ-MPEA (化合物 20) はイブルチニブ誘導体です。イブルチニブは、血液悪性腫瘍の治療に使用されているブルトン型チロシンキナーゼ (BTK) の共有結合的かつ不可逆的な阻害剤です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1710768-30-1
Sample solution is provided at 25 µL, 10mM.
Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1].
[1]. Liu N, et al. Direct and two-step bioorthogonal probes for Bruton's tyrosine kinase based on ibrutinib: a comparative study. Org Biomol Chem. 2015 May 14;13(18):5147-57.
Average Rating: 5
(Based on Reviews and 34 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *